Corey Davis | LifeSci Advisors |
Glenn Mattes | President and CEO |
Dale Christensen | Director of Clinical Development |
Bill Williams | University of Texas, Austin |
Kirk Coleman | CFO |
Chris Cano | COO |
Jonathan Aschoff | ROTH Capital Partners |
Daniel Carlson | TW Research Group |
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Fourth Quarter and Year-End 2021 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to your host, Corey Davis of LifeSci Advisors.
You may begin your conference at this time.
Thank you, operator. Hello, everyone, and welcome to the TFF Pharmaceuticals fourth quarter and year-end '21 financial and business results conference call.